Physician profile
Jonathan D Hardersen
NPI 1770687303
$991.57
in general payments reported to CMS, 2019-2025
7 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2022: $68.87 · 2023: $85.55 · 2024: $80.63 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $445.76 | 2021-2025 | Wegovy |
| Medtronic, INC. | $324.21 | 2021-2025 | Ligasure, Signia |
| Lilly USA, LLC | $104.32 | 2022-2025 | Zepbound |
| Phathom Pharmaceuticals, INC. | $68.84 | 2024-2025 | Voquezna |
| Itamar Medical INC | $18.54 | 2024 | Watchpatone |
| Takeda Pharmaceuticals U.S.A., INC. | $15.23 | 2021 | |
| Currax Pharmaceuticals LLC | $14.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Hardersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.